VIVANZABIOSCIENCESLTD logo

Vivanza Biosciences Ltd

VIVANZABIOSCIENCESLTD·NSE·
0.00 +0.00 (+0.00%)
Market Cap7.10 Cr
PE Ratio16.20
Volume
Day High - Low
52W High-Low2.72 - 1.52
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
0.3/10
Poor
Fair Value
Sign in to see
ROE
9.38%
Average
P/E
16.20x
Fair
Debt / Equity
2.00
High
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

52W1.52
2.72
DocStoX take

Supported by growth (9.0), but held back by risk (0.0). Growth looks strong at 9.0, but that is offset by risk at 0.0 and quality at 0.4. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.

DocStoX score

Medium confidence
0.3
/10
Poor
Quality
Weak
ROE 9.4%
Valuation
Rich
P/E 16.2×
Growth
Strong
Revenue +63.3% 5Y CAGR
Risk
High risk
D/E 2.00
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹7 Cr
52W High / Low
₹3 / ₹2
Dividend Yield
0.00%
Promoter Holding
20.02%
EPS (TTM)
₹0.10
Book Value
₹1.09

Key highlights

  • Revenue compounding 63% a year
  • High leverage — debt is 2.0× equity
  • Loss-making in some of the last 5 years
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Vivanza Biosciences Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.